PT  - JOURNAL ARTICLE
AU  - Lewis J. Rubin
AU  - Gerald Simonneau
AU  - David Badesch
AU  - Nazzareno Galiè
AU  - Marc Humbert
AU  - Anne Keogh
AU  - Joseph Massaro
AU  - Marco Matucci Cerinic
AU  - Olivier Sitbon
AU  - Steven Kymes
TI  - The study of risk in pulmonary arterial hypertension
AID  - 10.1183/09059180.00003712
DP  - 2012 Sep 01
TA  - European Respiratory Review
PG  - 234--238
VI  - 21
IP  - 125
4099  - http://err.ersjournals.com/content/21/125/234.short
4100  - http://err.ersjournals.com/content/21/125/234.full
SO  - EUROPEAN RESPIRATORY REVIEW2012 Sep 01; 21
AB  - A growing body of published evidence exists on the risk factors for disease progression in pulmonary arterial hypertension (PAH). The Scientific Steering Committee for the Study of Risk in PAH was established to bring together leading clinical and statistical experts in PAH and risk modelling, for the purpose of advancing the understanding of the risk of development and progression of PAH. Herein, we discuss the impact of this information on three key areas: 1) clinical decision-making; 2) policy and reimbursement; and 3) future trials and research.